专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明申请

WO2003007314A1 POLYVINYLIDENE FLUORIDE COMPOSITES AND METHODS FOR PREPARING SAME 审中-公开
标题翻译：聚亚苄基氟化物复合材料及其制备方法
公开(公告)号：WO2003007314A1
公开(公告)日：2003-01-23
申请号：PCT/US2002/021754
申请日：2002-07-10
申请人： HYPERION CATALYSIS INTERNATIONAL, INC.
发明人： NIU, Chunming , NGAW, Lein , FISCHER, Alan , HOCH, Robert
IPC分类号： H01B1/24
CPC分类号： B82Y10/00 , B82Y30/00 , C08J3/212 , C08J2327/16 , C08K7/24 , H01B1/24 , Y10S977/742 , Y10S977/788 , C08L27/16
摘要： An electrically conductive composite comprising a polyvinylidene fluoride polymer or copolymer and carbon nanotubes is provided. Preferably, carbon nanotubes may be present in the range of about 0.5-20% by weight of the composite. The composites are prepared by dissolving the polymer in a first solvent to form a polymer solution and then adding the carbon nanotubes into the solution. The solution is mixed using an energy source such as a sonicator or a Waring blender. A precipitating component is added to precipitate out a composite comprising the polymer and the nanotubes. The composite is isolated by filtering the solution and drying the composite. The composites are also prepared by mixing or dispersing carbon nanotubes in polymer emulsion using an energy source such as a Waring blender. The liquid in the mixture is then evaporated to obtain the composite comprising the polymer and the nanotubes.
摘要翻译：提供了包含聚偏二氟乙烯聚合物或共聚物和碳纳米管的导电复合材料。优选地，碳纳米管可以以该复合材料的约0.5-20重量％的范围存在。通过将聚合物溶解在第一溶剂中以形成聚合物溶液，然后将碳纳米管加入到溶液中来制备复合材料。使用诸如超声波发生器或Waring混合器的能量源将溶液混合。加入沉淀组分以沉淀出包含聚合物和纳米管的复合材料。通过过滤溶液并干燥复合物来分离复合物。复合材料还可以通过使用诸如Waring混合器的能量源将碳纳米管混合或分散在聚合物乳液中来制备。然后将混合物中的液体蒸发，得到包含聚合物和纳米管的复合材料。

12. 发明申请

WO2002034933A3 METHODS AND COMPOSITIONS FOR MODIFYING BIOLOGICALLY ACTIVE TARGET MOLECULES 审中-公开
公开(公告)号：WO2002034933A3
公开(公告)日：2002-05-02
申请号：PCT/US2001/031663
申请日：2001-10-10
申请人： IGEN INTERNATIONAL, INC.
发明人： MARTIN, Mark, T.
IPC分类号： A61K38/43
摘要： The present invention provides a method of modifying a target substance by contacting the target substance with a catalyst that catalyzes the modification of the target substance. In a preferred embodiment, the method comprises labeling a target substance by contacting the target substance with a label and a catalyst that catalyzes the attachment of the label to the target substance. Preferably, the catalyst catalyses selectively the reaction between a specific target molecule and a specific label. The attachment of labels may be used to inactivate a biologically active target substance or otherwise modulate its activity. Alternatively, the method may be used to label the target molecule with a detectable label suitable for the sensitive detection of the target substance.

13. 发明申请

WO2001079285A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION 审中-公开
标题翻译：用于治疗纤维状况和强制性肺功能并增强淋巴细胞生成的方法和组合物
公开(公告)号：WO2001079285A1
公开(公告)日：2001-10-25
申请号：PCT/US2001/012126
申请日：2001-04-13
申请人： CLARAGEN, INC.
发明人： PILON, Aprile, L. , WELCH, Richard, W. , FARROW, Jeffrey , MELBY, James , WIESE, Laura , LOHNAS, Gerald , MIELE, Lucio , ANTICO, Giovanni
IPC分类号： C07K14/47
CPC分类号： C07K14/705 , A61K38/1709 , C07K14/70596
摘要： The present invention provides methods and compositions to treat fibrotic conditions, to increase lymphocyte production in vivo , and to improve and/or normalize lung function, pulmonary compliance, blood oxygenation, and blood pH to inhibit inflammatory processes to stimulate or inhibit pro-inflammatory and immune cells, and to inhibit migration of vascular endothelial cells. The invention contemplates the administration of human uteroglobin, native or recombinant, as a means of achieving these ends. Specifically, it has been found that uteroglobin inhibits cell adhesion to fibronectin, increases lymphocyte production in vivo , and improves and/or normalizes lung function, pulmonary compliance, blood oxygenation, and blood pH, and inhibits inflammatory process. In addition it has been found that uteroglobin can stimulate or inhibit pro-inflammatory and immune cells and inhibitor migration of vascular endothelial cells.
摘要翻译：本发明提供了治疗纤维化病症，增加体内淋巴细胞产生的方法和组合物，以及改善和/或正常化肺功能，肺顺应性，血氧饱和度和血液pH以抑制炎症过程刺激或抑制促炎症和免疫细胞，并抑制血管内皮细胞的迁移。本发明考虑将天然或重组的人类子宫肌钙蛋白的施用作为实现这些目的的手段。具体地，已经发现，子宫肌钙蛋白抑制纤维连接蛋白的细胞粘附，增加体内的淋巴细胞产生，并改善和/或使肺功能，肺顺应性，血氧饱和度和血液pH值正常化，并抑制炎症过程。此外，已经发现，子宫肌钙蛋白可以刺激或抑制促炎和免疫细胞和抑制血管内皮细胞的迁移。

14. 发明申请

WO2013119740A1 WATER REACTIVE HYDROGEN FUEL CELL POWER SYSTEM 审中-公开
标题翻译：水反应氢燃料电池系统
公开(公告)号：WO2013119740A1
公开(公告)日：2013-08-15
申请号：PCT/US2013/025039
申请日：2013-02-07
申请人： SIGNA CHEMISTRY, INC. , WALLACE, Andrew, P. , MELACK, John, M. , LEFENFELD, Michael
发明人： WALLACE, Andrew, P. , MELACK, John, M. , LEFENFELD, Michael
IPC分类号： B01J7/02
CPC分类号： B01J7/02 , C01B3/06 , C01B3/065 , C01B2203/066 , Y02E60/362
摘要： A water reactive hydrogen fueled power system includes devices and methods to combine reactant fuel materials and aqueous solutions to generate hydrogen. The generated hydrogen is converted in a fuel cell to provide electricity. The water reactive hydrogen fueled power system includes a fuel cell, a water feed tray, and a fuel cartridge to generate power for portable power electronics. The removable fuel cartridge is encompassed by the water feed tray and fuel cell. The water feed tray is refillable with water by a user. The water is then transferred from the water feed tray into the fuel cartridge to generate hydrogen for the fuel cell which then produces power for the user.
摘要翻译：水反应性氢燃料动力系统包括将反应物燃料和水溶液组合以产生氢的装置和方法。所产生的氢气在燃料电池中转化以提供电力。水反应性氢燃料电力系统包括燃料电池，供水盘和用于为便携式电力电子产生电力的燃料盒。可拆卸的燃料盒被供水盘和燃料电池包围。供水托盘可由用户重新填充水。然后将水从供水盘传送到燃料盒中，以产生用于燃料电池的氢气，然后为用户产生电力。

15. 发明申请

WO2010138846A1 ENDOPROTHESIS STENT DELIVERY SYSTEM AND METHOD OF USING THE SAME 审中-公开
标题翻译：内窥镜输送系统及其使用方法
公开(公告)号：WO2010138846A1
公开(公告)日：2010-12-02
申请号：PCT/US2010/036627
申请日：2010-05-28
申请人： PERNA, Anna, Maria , MULUMUDI, Mahesh, S. , ABOUFARES, Ali
发明人： MULUMUDI, Mahesh, S. , ABOUFARES, Ali
IPC分类号： A61F2/06
CPC分类号： A61F2/958 , A61F2/966 , A61F2/97 , A61F2002/9517
摘要： An endoprothesis deployment system includes an axial catheter, an outer sheath extending parallel to the axial catheter, and an inner sheath positioned transversely between the axial catheter and outer sheath, the inner sheath including first and second inner sheath sections extending along the axial catheter, each of said first and said second inner sheath sections mounted for axial movement relative to the other inner sheath section.
摘要翻译：内部支架展开系统包括轴向导管，平行于轴向导管延伸的外护套和横向位于轴向导管和外护套之间的内护套，内护套包括沿着轴向导管延伸的第一和第二内护套部分，所述第一和第二内护套部分安装成相对于另一个内护套部分轴向移动。

16. 发明申请

WO2007131199A2 COSMETIC METHOD AND KIT FOR TREATMENT OF SPIDER VEINS AND OTHER SUPERFICIAL VENOUS PATHOLOGY 审中-公开
标题翻译：用于治疗天空病毒和其他超声门静脉病变的化妆方法和药盒
公开(公告)号：WO2007131199A2
公开(公告)日：2007-11-15
申请号：PCT/US2007/068290
申请日：2007-05-04
申请人： NAVARRO, Luis , NAVARRO, Nester , BONE SALAT, Carlos
发明人： NAVARRO, Luis , NAVARRO, Nester , BONE SALAT, Carlos
IPC分类号： A61B18/18
CPC分类号： A61B18/203 , A61B2018/00452 , A61B2018/00458
摘要： A method is disclosed for treating superficial venous pathology in a patient. The method comprises the steps of: (a) percutaneously piercing a spider or reticular vein to be treated; and (b) directing intense pulse or laser light at the patient's skin predominantly within the area of skin manifesting physical, chemical and/or color changes caused by step (a). In a preferred method sclerotherapy is performed on the spider or reticular vein to be treated and then laser light is directed at the patient's skin substantially entirely within the area of skin manifesting the changes.
摘要翻译：公开了一种治疗患者浅层静脉病理学的方法。该方法包括以下步骤：（a）经皮穿刺待处理的蜘蛛或网状静脉; 和（b）主要在皮肤区域内引导强烈的脉冲或激光在患者的皮肤上，表现出由步骤（a）引起的物理，化学和/或颜色变化。在优选的方法中，对待治疗的蜘蛛或网状静脉进行硬化疗法，然后将激光基本上完全指向表现出变化的皮肤区域内的患者皮肤。

17. 发明申请

WO2007048099A2 ANTIMICROBIAL COLLAGENOUS CONSTRUCTS 审中-公开
标题翻译：抗菌胶原蛋白
公开(公告)号：WO2007048099A2
公开(公告)日：2007-04-26
申请号：PCT/US2006/060055
申请日：2006-10-18
申请人： Organogenesis, Inc. , ABRAHAM, Ginger, A. , NIXON, Andrew, J.
发明人： ABRAHAM, Ginger, A. , NIXON, Andrew, J.
IPC分类号： A61K35/37
CPC分类号： A61L27/3629 , A61L27/18 , A61L27/24 , A61L27/3683 , A61L27/54 , A61L2300/104 , A61L2300/404 , A61L2300/604 , C08L71/02
摘要： Bioengineered collagen constructs with antimicrobial properties are provided. The bioengineered collagen constructs comprise a sheet-like layer of purified collagenous tissue matrix derived from a tissue source, such as the tunica submucosa of small intestine or a processed intestinal collagen layer derived from the tunica submucosa of small intestine, treated with an antimicrobial agent. The constructs arc biocompatible. The present invention has a variety of applications, including wound dressing and surgical repair devices. Methods for treating a damaged or diseased soft tissue are provided. Methods for treating a wound in need of care and treatment are also disclosed.
摘要翻译：提供具有抗菌性能的生物工程胶原构建体。生物工程胶原构建体包含衍生自组织来源的纯化胶原组织基质的片状层，例如小肠粘膜下层或由抗微生物剂处理的来自小肠粘膜下层的加工肠胶原层。构建体具有生物相容性。本发明具有各种应用，包括伤口敷料和手术修复装置。提供了治疗损伤或患病软组织的方法。还公开了治疗需要护理和治疗的伤口的方法。

18. 发明申请

WO2007035442A2 CONDUCTIVE SILICONE AND METHODS FOR PREPARING SAME 审中-公开
标题翻译：导电硅胶及其制备方法
公开(公告)号：WO2007035442A2
公开(公告)日：2007-03-29
申请号：PCT/US2006/035922
申请日：2006-09-15
申请人： HYPERION CATALYSIS INTERNATIONAL, INC. , ZHOU, Chaohui , FISCHER, Alan
发明人： ZHOU, Chaohui , FISCHER, Alan
IPC分类号： H01L21/02
CPC分类号： H01B1/24 , B82Y30/00 , C08J5/005 , C08J2383/04 , C08K3/041 , C08K7/00 , C08L83/04
摘要： Methods of preparing conductive silicones containing carbon nanotubes is provided. The carbon nanotubes may be in individual form or in the form of aggregates having a macromorpology resembling the shape of a cotton candy, bird nest, combed yarn or open net. Preferred multiwalled carbon nanotubes have diameters no greater than 1 micron and preferred single walled carbon nanotubes have diameters less than 5 nm. Carbon nanotubes may be adequately dispersed in a silicone base resin by known conventional equipments and processes to prepare conductive silicone base resins. The conductive silicone base resin is then mixed with a curing agent to form conductive silicone elastomers.
摘要翻译：提供了制备含有碳纳米管的导电硅氧烷的方法。碳纳米管可以是具有类似于棉花糖，鸟巢，精梳纱或开放网的形状的大体积学的聚集体的单独形式或形式。优选的多壁碳纳米管的直径不大于1微米，优选的单壁碳纳米管的直径小于5nm。可以通过已知的常规设备和方法将碳纳米管充分分散在硅树脂基树脂中以制备导电硅树脂基树脂。然后将导电硅树脂基树脂与固化剂混合以形成导电硅橡胶。

19. 发明申请

WO2006130150A2 FUNCTIONALIZED SINGLE WALLED CARBON NANOTUBES 审中-公开
标题翻译：功能齐全的单壁碳纳米管
公开(公告)号：WO2006130150A2
公开(公告)日：2006-12-07
申请号：PCT/US2005/022413
申请日：2005-06-23
申请人： HYPERION CATALYSIS INTERNATIONAL, INC. , HOCH, Robert , FISCHER, Alan , TENNENT, Howard
发明人： HOCH, Robert , FISCHER, Alan , TENNENT, Howard
CPC分类号： B01J31/003 , B01J21/185 , B82Y30/00 , B82Y40/00 , C01B32/174 , C01B2202/02 , C01B2202/36 , D01F11/12 , D01F11/14 , H01M4/587 , H01M4/625 , H01M8/18 , Y02E60/528
摘要： Graphitic nanotubes, which includes tubular fullerenes (commonly called "buckytubes") and fibrils, which are functionalized by chemical substitution or by adsorption of functional moieties. More specifically the invention relates to single walled carbon nanotubes having diameters than 5 nanometers which are uniformly or non-uniformly substituted with chemical moieties or upon which certain cyclic compounds are adsorbed and to complex structures comprised of such functionalized nanotubes linked to one another. The invention also relates to methods for introducing functional groups onto the surface of such nanotubes. The invention further relates to uses for functionalized single walled carbon nanotubes.
摘要翻译：石墨纳米管，其包括管状富勒烯（通常称为“巴氏管”）和原纤维，其通过化学取代或功能部分的吸附官能化。更具体地，本发明涉及直径大于5纳米的单壁碳纳米管，其均匀或不均匀地被化学部分取代或者其上吸附某些环状化合物，以及由相互连接的这种官能化纳米管组成的复合结构。本发明还涉及在这种纳米管的表面上引入官能团的方法。本发明还涉及功能化单壁碳纳米管的用途。

20. 发明申请

WO2005074835A1 HYDROPHILIC MATRIX FOR DELIVERY OF ACTIVE AGENT AND PRODUCT CONTAINING SAME 审中-公开
标题翻译：用于输送活性剂和含有其的产物的水解基质
公开(公告)号：WO2005074835A1
公开(公告)日：2005-08-18
申请号：PCT/US2005/003383
申请日：2005-02-02
申请人： HYDROPHILIX CORPORATION , THOMSON, Timothy
发明人： THOMSON, Timothy
IPC分类号： A61F2/02
CPC分类号： A61K9/2031 , A61K9/127 , A61K47/06 , A61K47/10 , A61K47/14 , A61K47/26
摘要： A sustained drug delivery system is disclosed comprising an open cell or reticulated, hydrophilic polyurethane.
摘要翻译：公开了一种持续的药物递送系统，其包括开孔或网状亲水性聚氨酯。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式